Showing results (51-60 of 1,895) with videos related to

Sort By:
Pageof 190
The Clinical Respiratory Journal|June 17, 2017
One minute sit-to-stand test is an alternative to 6MWT to measure functional exercise performance in COPD patientsGregory Reychler, Eliott Boucard, Loïc Peran, et al.
The Clinical Respiratory Journal|May 26, 2017
The prevalence of asthma and related symptoms in Middle East countriesAzam Alavinezhad, Mohammad Hossein Boskabady
The Clinical Respiratory Journal|May 26, 2017
Comprehensive genetic study of cystic fibrosis in Slovak patients in 25 years of genetic diagnosticsAndrea Soltysova, Eva Tothova Tarova, Andrej Ficek, et al.
The Clinical Respiratory Journal|June 16, 2017
Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapyYun Hee Lee, Hoon-Sik Choi, Hojin Jeong, et al.
The Clinical Respiratory Journal|September 11, 2016
A case report of acute fibrinous and organizing pneumonia with pneumothorax and avian exposure historyKam Yu Chiu, Jian Guo Li, Ying Ying Gu
The Clinical Respiratory Journal|February 11, 2022
Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID-19)Wang Chun Kwok, Anthony Raymond Tam, James Chung Man Ho, et al.
The Clinical Respiratory Journal|January 26, 2022
Balance impairment and cognitive dysfunction in patients with chronic obstructive pulmonary disease under 65 yearsMelike Hanim Kaygusuz, Ozge Oral Tapan, Utku Tapan, et al.
The Clinical Respiratory Journal|November 1, 2021
Nasal high flow therapy use in wards in patients with chronic obstructive pulmonary disease may spare ICU resourcesMatthew W Trump, Iaswarya Ganapathiraju, Julie A Jackson, et al.
The Clinical Respiratory Journal|November 20, 2023
Analysis of characteristics related to interstitial lung disease or pulmonary hypertension in patients with dermatomyositisChulin Wang, Han Yang, Tongfen Li, et al.
The Clinical Respiratory Journal|November 10, 2023
Rationale and design of a multicenter, randomized phase II trial of durvalumab with or without multitarget tyrosine kinase inhibitor as maintenance treatment in extensive-stage small-cell lung cancer patients (DURABLE study)Bo Zhang, Hua Zhong, Chunlei Shi, et al.
Pageof 190